Article
Author(s):
Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.
The trial over the 2012 fungal meningitis outbreak involving New England Compounding Center (NECC) pharmacist Barry Cadden, is underway. Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.
Here’s what you need to know about the trial so far:
Lawyers allege that NECC pharmacists produced tainted steroids that led to 750 meningitis infections nationwide and 64 deaths. After the meningitis outbreak, authorities traced it back to the NECC and alleged that Cadden and other employees ignored industry regulations and safety standards, resulting in widespread contamination.
Cadden has been charged with 25 counts of murder and other offenses under federal racketeering laws.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.